You are here:

NICE
NICE Guidance
Conditions and diseases
Kidney conditions
Renal cancer

Renal cancer Products

A list of all our products on renal cancer

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceInterventional procedures guidanceMedical technologies guidance

Status
1 selected

StatusPublishedIn developmentAwaiting developmentTopic selection

New and updated

New and updatedNew in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Nivolumab with ipilimumab for adjuvant treatment of localised renal cell carcinoma TS ID 9659
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Belzutifan with lenvatinib for treating advanced renal cell carcinoma after a PD-1 or PD-L1 inhibitor ID 6476
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC